|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.62 USD | +0.55% |
|
+4.78% | +28.86% |
| 08:34pm | Guardant Health Set to Benefit From Genomic Profiling Growth, RBC Says | MT |
| 03:24pm | RBC Initiates Guardant Health at Outperform With $185 Price Target | MT |
| Market Cap | 1.74TCr 1.5TCr 1.38TCr 1.29TCr 2.42TCr 1,65000Cr 2.46TCr 16TCr 6.36TCr 80TCr 6.51TCr 6.38TCr 2,78000Cr | P/E Ratio 2026 * |
-45.1x | P/E Ratio 2027 * | -63.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.79TCr 1.54TCr 1.42TCr 1.33TCr 2.49TCr 1,69800Cr 2.53TCr 17TCr 6.55TCr 83TCr 6.71TCr 6.56TCr 2,86200Cr | EV / Sales 2026 * |
13.6x | EV / Sales 2027 * | 10.5x |
| Free-Float |
95.75% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Guardant Health, Inc.
| 1 day | +0.55% | ||
| 1 week | +4.78% | ||
| Current month | +1.49% | ||
| 1 month | +31.70% | ||
| 3 months | +56.65% | ||
| 6 months | +28.95% | ||
| Current year | +28.86% |
| 1 week | 122.76 |  | 133.66 |
| 1 month | 92.5 | | 134.28 |
| Current year | 74.55 | | 134.28 |
| 1 year | 40.36 | | 134.28 |
| 3 years | 15.81 | | 134.28 |
| 5 years | 15.81 | | 134.28 |
| 10 years | 15.81 | | 181.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
AmirAli Talasaz
CEO | Chief Executive Officer | 46 | 05/08/2021 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 47 | 01/01/2013 |
Michael Bell
DFI | Director of Finance/CFO | 57 | 05/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmy Eltoukhy
CHM | Chairman | 47 | 05/08/2021 |
AmirAli Talasaz
CHM | Chairman | 46 | 01/01/2013 |
Ian Clark
BRD | Director/Board Member | 65 | 01/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/06 | Sell | Chief Financial Officer | -2,000 | 0.0015% | ||
| 05/06 | Sell | Chief Executive Officer | -1,00,000 | 0.0754% | ||
| 04/06 | Sell | Director | -9,294 | 0.0070% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.55% | +4.78% | +168.50% | +278.98% | 1.74TCr | |
| -1.74% | -7.70% | -44.51% | -25.68% | 937.19Cr | |
| +0.19% | +3.51% | +30.42% | +24.46% | 679.19Cr | |
| -0.17% | +8.98% | - | - | 508.83Cr | |
| -0.39% | +0.21% | -31.90% | -24.73% | 507.33Cr | |
| -2.92% | -7.77% | -29.69% | -31.24% | 418.36Cr | |
| -1.36% | -17.61% | +62.18% | +48.54% | 381.3Cr | |
| -0.72% | -7.09% | +172.59% | -48.36% | 368.81Cr | |
| +0.64% | +2.22% | -19.35% | -42.41% | 261.94Cr | |
| +0.14% | -5.46% | -27.62% | -16.61% | 244.92Cr | |
| Average | -0.58% | -3.44% | +31.18% | +18.10% | 604.36Cr | |
| Weighted average by Cap. | -0.44% | -2.95% | +57.52% | +78.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 131.41Cr 113.5Cr 104.59Cr 98Cr 183.47Cr 12TCr 186.32Cr 1.23TCr 481.5Cr 6.08TCr 493.19Cr 482.69Cr 21TCr | 169.99Cr 146.82Cr 135.29Cr 126.64Cr 237.33Cr 16TCr 241.01Cr 1.6TCr 622.85Cr 7.86TCr 637.96Cr 624.38Cr 27TCr |
| Net income | -38Cr -33Cr -30Cr -28Cr -53Cr -3.61TCr -54Cr -357.07Cr -139.22Cr -1.76TCr -142.59Cr -139.56Cr -6.09TCr | -26Cr -22Cr -20Cr -19Cr -36Cr -2.43TCr -36Cr -240.69Cr -94Cr -1.18TCr -96Cr -94Cr -4.1TCr |
| Net Debt | 51Cr 44Cr 41Cr 38Cr 71Cr 4.87TCr 73Cr 481.09Cr 187.57Cr 2.37TCr 192.12Cr 188.03Cr 8.2TCr | 44Cr 38Cr 35Cr 33Cr 62Cr 4.23TCr 63Cr 417.96Cr 162.96Cr 2.06TCr 166.91Cr 163.36Cr 7.12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 131.62 $ | +0.55% | 14,61,189 |
| 11/26/11 | 130.90 $ | +0.15% | 15,02,610 |
| 10/26/10 | 130.70 $ | +0.45% | 17,97,499 |
| 09/26/09 | 130.12 $ | +4.19% | 22,58,295 |
| 08/26/08 | 124.89 $ | -0.57% | 22,13,894 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition